Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quezada

Showing results (41-50 of 236) with videos related to

Pageof 24
Sort By:
Cancer Discovery|August 2, 2024
Lung Cancer Adoptive Cell Therapy: Inspiring TIL ACT Comes Center StageMichael T Lotze, Markus Maeurer, Sergio A Quezada, et al.
Cureus|January 30, 2026
NextGenDO: A Pre-medical Outreach Program to Promote Early Exposure to Osteopathic MedicineKenneth A Quezada, Ledio Gjunkshi, Nadiya A Persaud, et al.
Revista Chilena De Pediatria|May 1, 1991
[Weber-Christian disease]M Avendaño, A Quezada, S Benveniste, et al.
Journal of Investigational Allergology & Clinical Immunology|March 23, 2002
Recurrent pneumonia as warning manifestation for suspecting primary immunodeficiencies in childrenA Quezada, X Norambuena, A Bravo, et al.
Cold Spring Harbor Perspectives in Medicine|June 21, 2017
The "Achilles' Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic StrategiesKroopa Joshi, Benjamin M Chain, Karl S Peggs, et al.
Molecules (Basel, Switzerland)|November 17, 2007
High throughput screening and QSAR-3D/CoMFA: useful tools to design predictive models of substrate specificity for biocatalystsJ D Carballeira, M A Quezada, E Alvarez, et al.
Immunological Reviews|April 15, 2011
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradicationSergio A Quezada, Karl S Peggs, Tyler R Simpson, et al.
Biotechnology and Bioengineering|December 22, 2007
Low-temperature synthesis of 2'-deoxyadenosine using immobilized psychrotrophic microorganismsJ Fernández-Lucas, L A Condezo, M A Quezada, et al.
Current Opinion in Immunology|February 9, 2006
Principles and use of anti-CTLA4 antibody in human cancer immunotherapyKarl S Peggs, Sergio A Quezada, Alan J Korman, et al.
The Journal of Clinical Investigation|June 17, 2006
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsSergio A Quezada, Karl S Peggs, Michael A Curran, et al.
Pageof 24

Showing results (41-50 of 236) with videos related to

Sort By:
Pageof 24
Cancer Discovery|August 2, 2024
Lung Cancer Adoptive Cell Therapy: Inspiring TIL ACT Comes Center StageMichael T Lotze, Markus Maeurer, Sergio A Quezada, et al.
Cureus|January 30, 2026
NextGenDO: A Pre-medical Outreach Program to Promote Early Exposure to Osteopathic MedicineKenneth A Quezada, Ledio Gjunkshi, Nadiya A Persaud, et al.
Revista Chilena De Pediatria|May 1, 1991
[Weber-Christian disease]M Avendaño, A Quezada, S Benveniste, et al.
Journal of Investigational Allergology & Clinical Immunology|March 23, 2002
Recurrent pneumonia as warning manifestation for suspecting primary immunodeficiencies in childrenA Quezada, X Norambuena, A Bravo, et al.
Cold Spring Harbor Perspectives in Medicine|June 21, 2017
The "Achilles' Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic StrategiesKroopa Joshi, Benjamin M Chain, Karl S Peggs, et al.
Molecules (Basel, Switzerland)|November 17, 2007
High throughput screening and QSAR-3D/CoMFA: useful tools to design predictive models of substrate specificity for biocatalystsJ D Carballeira, M A Quezada, E Alvarez, et al.
Immunological Reviews|April 15, 2011
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradicationSergio A Quezada, Karl S Peggs, Tyler R Simpson, et al.
Biotechnology and Bioengineering|December 22, 2007
Low-temperature synthesis of 2'-deoxyadenosine using immobilized psychrotrophic microorganismsJ Fernández-Lucas, L A Condezo, M A Quezada, et al.
Current Opinion in Immunology|February 9, 2006
Principles and use of anti-CTLA4 antibody in human cancer immunotherapyKarl S Peggs, Sergio A Quezada, Alan J Korman, et al.
The Journal of Clinical Investigation|June 17, 2006
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsSergio A Quezada, Karl S Peggs, Michael A Curran, et al.
Pageof 24